Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
359 Results Found
Study: Price hikes for half of Medicare-covered drugs exceed inflation
Drug companies raised prices faster than inflation for about half of all drugs covered by Medicare between July 2019 and July 2020, according to an analysis released last week by the Kaiser Family Foundation.
CMS formally rescinds most-favored nation drug proposal
The Centers for Medicare & Medicaid Services Dec.
Rule requires health plans to submit prescription drug, health care spending data
The administration issued an interim final rule requiring health plans to begin submitting annual information next year on prescription drug coverage and spending, including the most frequently dispensed and costliest drugs, and information on prescription drug rebates and their impact on premiums and out-of-pocket spending.
Blog: Analysis on drug prices fails to provide full context
In addition to being based on a very small sample size, a recently published study on hospital costs for clinician-administered drugs under Medicare Part B does not provide direct insight as to what hospitals actually pay to acquire these drugs, writes Aaron Wesolowski, vice president of policy research, analytics and strategy at AHA.
Blog: Analysis on Drug Prices Fails to Provide Full Context
The authors of a recent analysis published in JAMA themselves acknowledge that their sample size is very small, making it hard to draw any sweeping conclusions based on their data. In addition, the study does not provide direct insight as to what hospitals actually pay to acquire these drugs.
AHA 340B Advocacy Alliance Bulletin: Register for AHA 340B Advocacy Alliance Call on Nov. 17
The AHA 340B Advocacy Alliance Nov. 17 at 3 p.m. ET will host a special call for AHA 340B hospital members to provide an update on the latest activity on the 340B Drug Pricing Program.
Walmart, Transcarent Team Up to Woo Self-Insured Employers
Walmart recently partnered with the consumer-facing health care platform Transcarent to provide low-cost prescription drugs, telehealth, optical and other services to self-insured employers.
AHA reiterates support for most-favored nation drug price rule’s withdrawal
The AHA restated its strong support for the Centers for Medicare & Medicaid Services’ withdrawal of its Most Favored Nation Model proposed rule.
AHA Comments on the Centers for Medicare & Medicaid Services’ Most Favored Nation Model Proposed Rule
This letter to CMS reiterates AHA’s position that the agency’s Most Favored Nation Proposed Rule should be withdrawn.
AHA, Others Urge Congressional Leaders to Protect 340B Program as They Consider Legislation Under Reconciliation
AHA, others express support of the 340B federal drug pricing program and strongly encourage Congress to protect the program as they consider broader changes to our nation’s health care system.